We are live on ! Find out more
MYOV

Myovant Sciences Ltd.
MYOV

Delisted

MYOV was delisted on the 9th of March, 2023.

Back to rankings

52 hedge funds and large institutions have $621M invested in Myovant Sciences Ltd. in 2016 Q4 according to their latest regulatory filings, with 52 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+52
Holders Change %
–
% of All Funds
1.3%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
52
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
QF
QVT Financial
New York
+$431M
2
BB
BB Biotech
Switzerland
+$37M
3
RCM
RA Capital Management
Massachusetts
+$17.4M
4
DM
Deerfield Management
New York
+$17.3M
5
SCM
Scopia Capital Management
New York
+$9.48M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
QF
1
QVT Financial
New York
$463M +$431M +37,231,342 New
BB
2
BB Biotech
Switzerland
$39.7M +$37M +3,192,835 New
RCM
3
RA Capital Management
Massachusetts
$18.7M +$17.4M +1,500,000 New
DM
4
Deerfield Management
New York
$18.6M +$17.3M +1,496,675 New
SCM
5
Scopia Capital Management
New York
$10.2M +$9.48M +817,747 New
Norges Bank
6
Norges Bank
Norway
$9.76M +$9.09M +784,783 New
BA
7
BlackRock Advisors
Delaware
$7.3M +$6.8M +586,442 New
Goldman Sachs
8
Goldman Sachs
New York
$5.78M +$5.38M +464,635 New
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$5.6M +$5.21M +450,000 New
TCM
10
Tekla Capital Management
Massachusetts
$4.98M +$4.63M +400,000 New
VOYA Investment Management
11
VOYA Investment Management
Georgia
$4.8M +$4.47M +385,962 New
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$4.35M +$4.06M +350,000 New
GPP
13
Great Point Partners
Connecticut
$4.35M +$4.06M +350,000 New
BFA
14
BlackRock Fund Advisors
California
$3.87M +$3.61M +311,323 New
BG
15
BlackRock Group
United Kingdom
$3.73M +$3.47M +299,549 New
PA
16
Perceptive Advisors
New York
$2.81M +$2.62M +226,322 New
State Street
17
State Street
Massachusetts
$1.27M +$1.19M +102,584 New
Alyeska Investment Group
18
Alyeska Investment Group
Illinois
$1.25M +$1.16M +100,404 New
CAM
19
Cormorant Asset Management
Massachusetts
$1.24M +$1.16M +100,000 New
RSCM
20
Rock Springs Capital Management
Maryland
$1.11M +$1.04M +89,600 New
BlackRock
21
BlackRock
New York
$1.11M +$1.03M +89,149 New
Northern Trust
22
Northern Trust
Illinois
$1M +$934K +80,645 New
SSA
23
Schonfeld Strategic Advisors
New York
$871K +$811K +70,000 New
JP Morgan Chase
24
JP Morgan Chase
New York
$791K +$737K +63,596 New
AA
25
ALPS Advisors
Colorado
$700K +$652K +56,239 New
1
2 3

MYOV Hedge Fund Activity: Q4 2016 in Review

52 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q4 2016, worth a combined $621M.

Buyers outnumbered sellers: 52 funds opened new MYOV positions and 0 closed out — a net gain of 52 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was QVT Financial, opening a new position worth an estimated $431M.

  • 52 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q4 2016, up from 0 in Q3 2016.
  • Funds reported $621M of Myovant Sciences Ltd. stock for Q4 2016.
  • 52 funds opened new Myovant Sciences Ltd. positions in Q4 2016 and 0 closed out, a net change of +52 holders.
  • The largest Myovant Sciences Ltd. buyer in Q4 2016 was QVT Financial, an estimated $431M added.

Based on aggregated 13F filings for Q4 2016.